+1 Recommend
1 collections
      • Record: found
      • Abstract: found
      • Article: found

      A Characterization of the Effects of Pentobarbital on Episodic LH Release in Ovariectomized Rats



      S. Karger AG

      Pentobarbital anesthesia, Pulsatile LH release, Ovariectomized rats

      Read this article at

          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.


          The effects of pentobarbital (PBTL) on pulsatile LH release in ovariectomized rats were studied and characterized. Unanesthetized rats were first bled continuously (50 μl whole blood every 5–6 min) through indwelling right atrial cannulae for 1½ h prior to PBTL injection (35 mg/kg). Animals were then bled for various periods of time during PBTL-induced anesthesia, as well as for 1½–2 h after recovery of the ½ righting reflex. Whole blood was analyzed for LH by radioimmunoassay. PBTL administration initially inhibited pulsatile LH release for 1¼–1½ h, after which episodic release resumed. For the remaining duration of anesthesia (3–3½ h) episodic LH release was characterized by decreased mean blood LH levels, a decreased rate and magnitude of increase in blood LH levels for individual episodes, and a lengthened periodicity between pulses. However, though reduced, episodic LH release remained stable despite the continued influence of anesthesia. In the 1½–2 h following recovery of the ½ righting reflex, only the periodicity of LH release returned to a pre-anesthesia interval. Mean blood LH levels and the rate at which blood LH levels changed during individual pulses remained reduced, and a slight fall occurred in the extent of the increase in blood LH levels during single LH episodes. The influence of PBTL on those brain regions responsible for controlling pulsatile LH release is therefore of longer duration than the effects of this anesthetic on central nervous system (CNS) areas, which when affected, results in loss of the ½ righting reflex.

          Related collections

          Author and article information

          S. Karger AG
          26 March 2008
          : 27
          : 5-6
          : 204-215
          Department of Physiology, University of California School of Medicine, San Francisco, Calif.
          122813 Neuroendocrinology 1978;27:204–215
          © 1978 S. Karger AG, Basel

          Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

          Page count
          Pages: 12


          Comment on this article